Coty Inc. is a global beauty company that specializes in the development, manufacturing, and marketing of a wide range of beauty products, including perfumes, cosmetics, and skincare solutions. With a diverse portfolio that includes both established and emerging brands, Coty aims to enhance the beauty experience for consumers through innovative and high-quality offerings. The company focuses on creating iconic fragrances, cutting-edge makeup products, and luxurious skincare treatments, catering to a variety of customer preferences and market segments. Through its commitment to sustainability and social responsibility, Coty continues to evolve its product lines and business practices to meet the changing needs of consumers around the world. Read More
Shares of beauty products company Coty (NYSE:COTY)
fell 4.6% in the afternoon session after Berenberg downgraded the stock to Hold from Buy, citing concerns about a delayed sales growth recovery. The investment firm also significantly cut its price target on the shares to $5.05 from $6.50. Berenberg's decision follows a period of underperformance for the stock and weaker-than-expected sales growth. The firm pointed to a weaker consumer outlook, inventory destocking, and potential headwinds from tariffs as reasons for its revised stance. The downgrade comes after Coty recently reported fourth-quarter results that missed earnings expectations, with a 9% year-over-year decline in like-for-like sales. The company's Prestige segment sales fell by 7%, while Consumer Beauty sales dropped by 12%. Reflecting these challenges, other analysts have also recently lowered their price targets for the beauty company.
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coty (COTY) To Contact Him Directly To Discuss Their Options
NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against AVITA Medical, Inc. (NASDAQ:RCEL), Coty Inc. (NYSE:COTY), and Sensus Healthcare, Inc. (NASDAQ:SRTS). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Coty (COTY) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Coty Inc. (“Coty” or “the Company”) (NYSE: COTY) for violations of the securities laws.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws.
Shares of beauty products company Coty (NYSE:COTY)
jumped 8.1% in the morning session after a company disclosure revealed that CEO Sue Nabi purchased $1 million worth of its stock.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Markets dipped Thursday as Coty issued a dismal forecast, Gilead faced headwinds with its new HIV drug, and investors turned cautious ahead of Fed Chair Powell’s Jackson Hole speech. Solid PMI data complicated the interest rate outlook, stalling hopes for imminent rate cuts.
The Law Offices of Frank R. Cruz announces an investigation of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) on behalf of investors concerning the Company’s possible violations of federal securities laws.
